USD 47 Mil as of today(2019-11-15). BMRN Non Operating Income explanation, calculation, historical data and more" />BMRN Non Operating Income | Biomarin Pharmaceutical - GuruFocus.com
Switch to:

Biomarin Pharmaceutical Non Operating Income

: USD 47 Mil (TTM As of Sep. 2019)
View and export this data going back to 1999. Start your Free Trial

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Biomarin Pharmaceutical's non-recurring items for the three months ended in Sep. 2019 was USD 3 Mil. Its non-recurring items for the trailing twelve months (TTM) ended in Sep. 2019 was USD 47 Mil.

As of today (2019-11-15), Biomarin Pharmaceutical's share price is USD 75.58. Biomarin Pharmaceutical's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2019 was USD -0.26. Therefore, Biomarin Pharmaceutical's PE Ratio without NRI ratio for today is .


Biomarin Pharmaceutical Non Operating Income Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.23 160.52 -594.73 131.68 51.65

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Non Operating Income Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.12 26.89 1.42 15.43 3.41

Biomarin Pharmaceutical Non Operating Income Calculation

Non-Recurring Items are the incomes received or expenses incurred by the business that are not from regular operations. Examples of NRI include gains (losses) from plant shutdown, lease-breaking fees, lawsuit, write-offs, write-downs, restructuring costs or sales of an investment, discontinued operations etc.

NRI can impact a company's reported income drastically.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2019 was 26.893 (Dec. 2018 ) + 1.423 (Mar. 2019 ) + 15.426 (Jun. 2019 ) + 3.409 (Sep. 2019 ) = USD 47 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

GuruFocus lists a PE Ratio without NRI, which is the price/earnings before NRI. We believe it more accurately reflects the valuation of the company.

Biomarin Pharmaceutical's PE Ratio without NRI Ratio for today is calculated as

PE Ratio without NRI=Share Price/EPS without NRI
=75.58/-0.26
=

Biomarin Pharmaceutical's Share Price of today is USD 75.58.
Biomarin Pharmaceutical's EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2019 was -0.03 (Dec. 2018 ) + -0.32 (Mar. 2019 ) + -0.21 (Jun. 2019 ) + 0.3 (Sep. 2019 ) = USD -0.26.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Biomarin Pharmaceutical Non Operating Income Related Terms

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)